Trial Details

RECRUITING
Basic Information
Clinical ID c1866
Identifier NCT06255834
Trial Title Phase 1 Study for IPG11406 in Health Volunteer
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: IPG11406
Participant Information
Sponsor Nanjing Immunophage Biotech Co., Ltd
City Hangzhou
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2024-02-24
Primary Completion Date 2025-02-28
Completion Date 2025-04-30